Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...